Laboratory diagnosis and biosafety issues of biological warfare agents

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Laboratory diagnosis and biosafety issues of biological warfare agents
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats  C. Nisii, C. Castilletti, A. Di Caro,
M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
R. Colebunders, P. Michielsen  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
Antimicrobial drug development – the past, the present, and the future
Clinical infection services—the Leiden experience
Training in infectious diseases—looking to the future
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Laboratory diagnosis and biosafety issues of biological warfare agents E. Nulens, A. Voss  Clinical Microbiology and Infection  Volume 8, Issue 8, Pages 455-466 (August 2002) DOI: 10.1046/j.1469-0691.2002.00528.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Laboratory Response Network laboratory levels* [5]. Clinical Microbiology and Infection 2002 8, 455-466DOI: (10.1046/j.1469-0691.2002.00528.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.